Posts

Adhesion Barrier Industry worth $0.9 billion by 2028, with a CAGR of 7.4%

  The report   " Adhesion Barrier Market  by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (Film, Gel, Liquid), Procedure (Abdominal, Cardiovascular, Gynae, Neurology), End User (Hospitals, Clinics & ASC), Region- Global Forecast to 2028" , is valued at an estimated USD 0.7 billion in 2023 and is projected to reach USD 0.9 billion by 2028, at a CAGR of 7.4% during the forecast period. The main drivers of this market's expansion are the rising number of surgeries and sports-related injuries, an increasing elderly population, and a growing understanding by of the adhesion formation and health issues linked to adhesions. On the other hand, during the forecast period, it is projected that surgeons' resistance to using adhesion barriers will impede market expansion. Browse 207 market data Tables and 50 Figures spread through 238 Pages and in-depth TOC on  "Adhesion Barrier Market by Product (Regenerated Cellulose, Hyaluronic Acid, PEG), Type (F...
Post a Comment
Read more

Epigenetics Industry worth $4.3 billion by 2028, with a CAGR of 18.3%

  The report   " Epigenetics Market  by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028 " , is projected to reach USD 4.3 billion by 2028 from USD 1.8 billion in 2023, at a CAGR of 18.3% during the forecast period of 2023 to 2028. Browse 367 market data Tables and 45 Figures spread through 366 Pages and in-depth TOC on  "Epigenetics Market by Product & Service (Enzymes (DNA-modifying Enzymes), Kits & Reagents (Antibodies), Instrument, Software), Method (DNA Methylation), Technique (NGS, PCR, Mass Spectrometry), Application (Oncology, Immunology) - Global Forecast to 2028 " View detailed Table of Content here  -  https://www.marketsandmarkets.com/Market-Reports/epigenetics-technologies-market-896.html The global epigenetics market is expected to ...
Post a Comment
Read more

3D Bioprinting Industry worth $2.4 billion by 2029, with a CAGR of 12.7%

  The report   " 3D Bioprinting Market  by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM), Application(Research (Regenerative Medicine, 3D cell Culture), Clinical (Skin, Bone)) - Global Forecast to 2029" , is projected to reach USD 2.4 billion by 2029 from USD 1.3 billion in 2024, at a CAGR of 12.7% during the forecast period The growth in the 3D bioprinting market is fueled by  growing adoption of 3D bioprinting technology within the pharmaceutical and cosmetic industries, advancement in the 3D bioprinting technology, rising public and private partnerships and collaborations, increasing investments in R&D and the expenditure on medical devices. Browse 530 market data Tables and 46 Figures spread through 453 Pages and in-depth TOC on  "3D Bioprinting Market by Component (3D bioprinters (Microextrusion, Inkjet, Laser), Bioinks, Software, Consumable), Material (Hydrogels, ECM)...
Post a Comment
Read more

eClinical Solutions Market Analysis: Opportunities and Emerging Trends

 The eClinical solutions market is experiencing significant growth, driven by technological advancements and the increasing complexity of clinical trials. Projected to expand from USD 11.6 billion in 2024 to USD 22.1 billion by 2029, at a CAGR of 13.7%, this market offers substantial opportunities for stakeholders in the pharmaceutical, biotechnology, and medical device sectors. Download PDF Brochure Key Market Drivers Adoption of Advanced Software Solutions in Clinical Research: The integration of novel software tools has revolutionized clinical trial processes, enhancing efficiency and reducing costs. Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) streamline data collection and management, minimizing errors and expediting study timelines. For instance, in November 2022, Medidata introduced Rave Companion, automating Rave EDC data capture and modernizing the user experience. Regulatory Compliance and Data Standardization: Regulatory authorities ...
Post a Comment
Read more

Cell Analysis Market Overview: Applications and Industry Insights

 The cell analysis market is experiencing significant growth, driven by advancements in technology and an increasing focus on personalized medicine. As of 2023, the global market was valued at approximately USD 20.2 billion and is projected to reach USD 33.9 billion by 2028, exhibiting a compound annual growth rate (CAGR) of 10.9% during the forecast period. Download PDF Brochure Key Market Players Several prominent companies are leading the cell analysis market: Thermo Fisher Scientific Inc.: A major player offering a wide range of cell analysis instruments and reagents. Danaher Corporation: Through its subsidiaries, Danaher provides advanced flow cytometry and imaging solutions. Becton, Dickinson and Company (BD): Known for its innovative flow cytometry and cell sorting technologies. Agilent Technologies Inc.: Offers a diverse portfolio, including cell analysis instruments and software. Merck KGaA: Provides a variety of products for cell analysis, including reage...
Post a Comment
Read more

Particle Size Analysis Market worth $596 million by 2028

  Particle Size Analysis Market in terms of revenue was estimated to be worth $446 million in 2023 and is poised to reach $596 million by 2028, growing at a CAGR of 6.0% from 2023 to 2028 according to a latest report published by MarketsandMarkets™. Market growth is attributed to the Escalating investments in research and development within the pharmaceutical sector, driving market expansion. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833 Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. The nanoparticle tracking analysis (NTA) technology segment is expected to witness the highest growth rate during the forecast period 2023 to 2028. The advanced capabilities provided by NTA find primary application in the biopharmaceutical and biotechnology sectors. The growi...
Post a Comment
Read more

Cochlear Implants Market to Hit US$4.73 Billion by 2030

  The global   cochlear implants market   valued at US$2.58 Billion in 2023, is forecasted to grow at a robust CAGR of 9.2%, reaching US$2.80 Billion in 2024 and an impressive US$4.73 Billion by 2030. The cochlear implants market is driven by factors such as the rising prevalence of hearing loss, particularly among the geriatric population, and the growing awareness of hearing rehabilitation options. Additionally, AI-enabled audio processing, paediatrics implantations for speech development, and advancement of surgical techniques create opportunities for better accessibility and improvement in the prognosis. The markets of emerging economies have a host of opportunities regarding developing low-cost implants and integrating telemedicine for managing the post-implant case. Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94935516 Browse in-depth TOC on “ Cochlear Implants Market ” 207 - Tables 46 - Figures 215 - Pages A cochlear implant ...
Post a Comment
Read more